Marvell-Lumentum Math Cuts Both Ways: Margins Hold, but the Per-Share Bill Is Still Blank

Stifel's model suggests a Marvell-Lumentum combination could stay inside Marvell's own long-term gross margin corridor — a finding that takes some of the sting out of the deal's most-cited profitability worry. But the same exercise leaves the question that actually moves the stock unanswered: what the transaction does to earnings per share.

Analyst Tore Svanberg pencils in a roughly 56.3% gross margin for the combined entity in fiscal 2027, against 58.6% for Marvell on a standalone basis. That lands within Marvell's stated long-term range of 56–59%. On the operating line the math is friendlier still: 37.8% combined versus 37.2% for Marvell alone, and that is before any synergies are counted.

The distinction matters. A softer gross margin does not mechanically translate into a weaker operating margin, because the two measure different levels of the income statement. What the model does not do is establish a price Marvell could economically justify — it is a scenario, not company guidance, and it substitutes neither for binding deal terms nor for proof that the two businesses can be integrated successfully.

A Growth Story That Has Already Moved

Timing sharpens the test. Early in October, Marvell raised its revenue target for fiscal 2028 to $20 billion from $15 billion. Any large acquisition now has to be measured against that already ambitious standalone trajectory. Scale alone would not prove higher economic value per share.

Raymond James frames the yardstick directly: a combination could be neutral to earnings per share in calendar 2028, or dilute that figure by more than 10%. Size and structure of the transaction would decide which. The firm nonetheless reaffirmed its strong buy rating and a $295 price target, having anticipated smaller bolt-ons rather than a deal of this magnitude.

Stifel, for its part, keeps its buy rating and a $370 target. Its positive case rests on a broader optical portfolio for AI infrastructure — integrated optics, laser supply and larger addressable markets among the potential drivers — and on an immediately positive effect on adjusted operating margin at closing. Those benefits would look far more convincing if financing at the per-share level did not consume them.

Strategic Logic Meets Customer Risk

Behind the numbers sit advanced takeover talks reported yesterday. Bloomberg, cited alongside Reuters, indicates an announcement could come as soon as next week, with a stock-based structure seen as likely — possibly entirely in shares. No agreement has been confirmed, and talks, terms and timing can all change or collapse.

RBC sees strategic merit: it expects the market for optical connectivity to outgrow overall data center spending over the next two to three years, and Lumentum's optical technology could complement Marvell's AI infrastructure offering. The flip side is delicate. Lumentum is itself a significant buyer of Marvell's DSP chips, and other customers could shift toward alternative suppliers once the two are under one roof. Marvell's share of that chip market is put at 60–65% — precisely the position that could erode if customers reorder their supply relationships. Possible alternative laser suppliers for Nvidia are among the risks flagged as well.

The Target's Own Starting Point

Lumentum's baseline is not yet a picture of strength. Its gross margin stands at 44.24%, and the company has been lossmaking over the past twelve months. Any improvement in combined earning power would therefore be an integration task rather than a documented result. Marvell, meanwhile, announced the $3.25 billion purchase of Celestial AI in 2025, raising the execution bar for another large transaction.

Financing adds its own layer: a share-based payment could dilute existing holders, while a takeover premium and lengthy approvals in the US and China — Stifel expects a prolonged review — add further uncertainty. Analysts also warn of significant equity or debt issuance, integration problems and extra margin volatility, with module makers potentially changing suppliers and squeezing Marvell's DSP position.

What the Next Headlines Must Answer

Until terms show a combination lifting operating margin without materially diluting earnings per share, the strategic argument holds together. If the conditions reveal heavy dilution or steeper integration costs, the extra revenue would have to be weighed against a smaller earnings slice for existing shareholders. A deal announcement next week is the obvious catalyst, though unconfirmed; the purchase price would matter less than concrete disclosure on payment form, margins and expected earnings contribution.

A firmer date on the calendar is Lumentum's quarterly report on November 5 after the US close, which could shed more light on the target's underlying economics. For Marvell holders, the real question is whether the transaction arithmetic persuades beyond the growth promise.